Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Capital Reinvestment Ratio
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Capital Reinvestment Ratio of 0.35x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥12.21 Million) in capital expenditures (CN¥4.26 Million). Check Hangzhou Coco Healthcare Products Co.Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Coco Healthcare Products Co.Ltd. Capital Reinvestment Ratio (2017–2024)
This chart tracks Hangzhou Coco Healthcare Products Co.Ltd.'s Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see 301009 operating cash flow.
Annual Capital Reinvestment Ratio for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
Year-by-year Capital Reinvestment Ratio for Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. See how much free cash does Hangzhou Coco Healthcare Products Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | CN¥52.44 Million | CN¥75.35 Million | ▲ +395.7% |
| 2023 | 0.29x | CN¥227.70 Million | CN¥66.01 Million | ▼ -93.9% |
| 2021 | 4.76x | CN¥50.53 Million | CN¥240.45 Million | ▲ +753.6% |
| 2020 | 0.56x | CN¥395.86 Million | CN¥220.71 Million | ▼ -1.1% |
| 2019 | 0.56x | CN¥223.33 Million | CN¥125.86 Million | ▼ -28.3% |
| 2018 | 0.79x | CN¥114.26 Million | CN¥89.78 Million | ▲ +11.4% |
| 2017 | 0.71x | CN¥109.74 Million | CN¥77.41 Million | — |